Karuna Appoints Atul Pande, M.D., To Board Of Directors

BOSTON--(BUSINESS WIRE)--Karuna Pharmaceuticals, a company focused on targeting muscarinic receptors for the treatment of central nervous system disorders, today announced the appointment of Atul Pande, M.D., to its Board of Directors. Dr. Pande brings to Karuna more than 25 years of experience in the fields of psychiatry and neurosciences and an expertise in drug development.

Back to news